| Code | CSB-MP855470HUh7 |
| Abbreviation | Recombinant Human CLEC4C protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CLEC4C, expressed on plasmacytoid dendritic cells, functions as a pattern recognition receptor that modulates innate immune responses and represents a target for immunotherapeutic intervention in autoimmune disease and cancer. This partial construct spanning residues 45–213 captures the extracellular C-type lectin domain responsible for ligand recognition and has been validated in functional ELISA, where immobilized protein binds an anti-CLEC4C recombinant antibody with an EC50 of 7.658–12.99 ng/mL, demonstrating preserved conformational epitopes suitable for therapeutic antibody epitope mapping and blocking antibody screening. Mammalian cell expression supports native glycosylation and disulfide bond formation critical for receptor folding, enabling reliable use in ligand-binding assays, competitive inhibition studies, and affinity characterization by surface plasmon resonance or biolayer interferometry. The protein meets quality thresholds commonly required for immunology research, with purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, aligning with standards expected in functional binding assays and antibody validation workflows.
There are currently no reviews for this product.